Effect of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Polymorphism Leu-214 on Replication Capacity and Drug Susceptibility

被引:12
作者
Carmen Puertas, Maria [1 ]
Jose Buzon, Maria [1 ]
Artese, Anna [2 ]
Alcaro, Stefano [2 ]
Menendez-Arias, Luis [3 ,4 ]
Perno, Carlo Federico [5 ]
Clotet, Bonaventura [1 ]
Ceccherini-Silberstein, Francesca [5 ]
Martinez-Picado, Javier [1 ,6 ]
机构
[1] IrsiCaixa Fdn, Hosp Germans Trias & Pujol, Badalona 08916, Spain
[2] Univ Catanzaro Magna Graecia, Dept Pharmacobiol Sci, Catanzaro, Italy
[3] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain
[4] Univ Autonoma Madrid, Madrid, Spain
[5] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[6] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain
关键词
RESISTANCE MUTATIONS; ANTIRETROVIRAL THERAPY; ZIDOVUDINE RESISTANCE; VIROLOGICAL RESPONSE; EXPERIENCED PATIENTS; COMBINATION THERAPY; IN-VITRO; HIV-1; PATTERNS; INHIBITORS;
D O I
10.1128/JVI.00487-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A negative association between polymorphism Leu-214 and type-1 thymidine analogue mutations (TAM1) and a positive association with a clinically favorable virological response to thymidine analogue-based combination antiretroviral therapy have been described. In this study, the impact of Leu-214 on replication capacity and resistance to zidovudine (ZDV) of viruses containing TAM1 or TAM2 was determined. Leu-214 decreased the growth rate of viruses bearing Tyr-215, as well as their resistance to ZDV. This observation was confirmed by structural and molecular modeling data, suggesting a regulatory role for Leu-214 in the emergence and phenotypic resistance of TAM1.
引用
收藏
页码:7434 / 7439
页数:6
相关论文
共 36 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]  
Alcaro S, 2000, J COMPUT CHEM, V21, P515, DOI 10.1002/(SICI)1096-987X(200005)21:7<515::AID-JCC2>3.0.CO
[3]  
2-5
[4]   High sequence conservation of human immunodeficiency virus-type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations [J].
Ceccherini-Silberstein, F ;
Gago, F ;
Santoro, M ;
Gori, C ;
Svicher, V ;
Rodríguez-Barrios, F ;
d'Arrigo, R ;
Ciccozzi, M ;
Bertoli, A ;
Monforte, AD ;
Balzarini, J ;
Antinori, A ;
Perno, CF .
JOURNAL OF VIROLOGY, 2005, 79 (16) :10718-10729
[5]   Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patients [J].
Ceccherini-Silberstein, Francesca ;
Cozzi-Lepri, Alessandro ;
Ruiz, Lidia ;
Mocroft, Amanda ;
Phillips, Andrew N. ;
Olsen, Christian Holkmann ;
Gatell, Jose M. ;
Gunthard, Huldrych F. ;
Reiss, Peter ;
Perno, Carlo Federico ;
Clotet, Bonaventura ;
Lundgren, Jens D. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (08) :1180-1190
[6]   The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions [J].
Cong, Mian-er ;
Heneine, Walid ;
Garcia-Lerma, J. Gerardo .
JOURNAL OF VIROLOGY, 2007, 81 (06) :3037-3041
[7]  
Cozzi-Lepri A, 2005, ANTIVIR THER, V10, P791
[8]   Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy [J].
De Luca, A ;
Di Giambenedetto, S ;
Romano, L ;
Gonnelli, A ;
Corsi, P ;
Baldari, M ;
Di Pietro, M ;
Menzo, S ;
Francisci, D ;
Almi, P ;
Zazzi, M .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (09) :1219-1222
[9]   A survival method to estimate the time to occurrence of mutations:: An application to thymidine analogue mutations in HIV-1-infected patients [J].
Flandre, P ;
Descamps, D ;
Joly, V ;
Meiffrédy, V ;
Tamalet, C ;
Izopet, J ;
Brun-Vézinet, F .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (05) :862-870
[10]  
Foley B.T., 1998, HUMAN RETROVIRUSES A, P102